Survivorship research based in integrated healthcare delivery systems - The Cancer Research Network

被引:15
作者
Geiger, Ann M. [1 ]
Buist, Diana S. M. [2 ]
Greene, Sarah M. [2 ]
Altschuler, Andrea [3 ]
Field, Terry S. [4 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Social Sci & Hlth Policy, Div Publ Hlth Sci, Winston Salem, NC 27157 USA
[2] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[3] Kaiser Permanente No California, Div Res, Oakland, CA USA
[4] Univ Massachusetts, Meyers Primary Care Inst, Med Sch & Fallon Community Hlth Plan, Worcester, MA 01605 USA
关键词
cancer; survivors; integrated delivery of healthcare; research;
D O I
10.1002/cncr.23447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. integrated healthcare delivery systems present unique opportunities for cancer survivorship research. The National Cancer Institute funds the Cancer Research Network (CRN) to leverage these capabilities for all types of cancer research, including survivorship. METHODS. The authors gathered information from a recent CRN funding application, Survivorship Interest Group materials, the CRN website, and published articles. CRN studies were selected to illustrate diverse topics and a variety of data-collection approaches. RESULTS. The 14 systems that participate in the CRN provide care for approximately 10.8 million individuals of all ages and racial/ethnic backgrounds, for whom approximately 38,000 new cancer diagnoses were made in 2005. CRN systems have the ability to use existing data and collect new data on patients, providers, and organizations through well established research centers staffed by independent scientists. Of the 45 funded and 2 pending CRN grant applications as of November 30, 2007, 21 include aspects related to cancer survivorship. These studies have examined clinical trial participation, patterns of care, age and racial/ethnic disparities, diffusion of clinical trial findings, treatment outcomes, surveillance, and end-of-life and palliative care. Breast, colorectal, lung, ovarian, and prostate cancers have been the focus of these studies. Results of these studies have been published widely in leading journals. CONCLUSIONS. Completed and ongoing CRN survivorship, studies provide a strong foundation for future studies. Scientists from all institutional affiliations are welcome to approach the CRN with ideas and are encouraged to allow ample time to establish collaborative relationships and design rigorous studies.
引用
收藏
页码:2617 / 2626
页数:10
相关论文
共 37 条
[1]   Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network [J].
Aiello, Erin J. ;
Buist, Diana S. M. ;
Wagner, Edward H. ;
Tuzzio, Leah ;
Greene, Sarah M. ;
Lamerato, Lois E. ;
Field, Terry S. ;
Herrinton, Lisa J. ;
Haque, Reina ;
Hart, Gene ;
Bischoff, Kimberly J. ;
Geiger, Ann M. .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (03) :397-403
[2]   Positive, negative, and disparate - Women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy [J].
Altschuler, Andrea ;
Nekhlyudov, Larissa ;
Rolnick, Sharon J. ;
Greene, Sarah M. ;
Elmore, Joann G. ;
West, Carmen N. ;
Herrinton, Lisa J. ;
Harris, Emily L. ;
Fletcher, Suzanne W. ;
Emmons, Karen M. ;
Geiger, Ann M. .
BREAST JOURNAL, 2008, 14 (01) :25-32
[3]  
[Anonymous], J NATL CANC I MONOGR
[4]  
[Anonymous], 2005, CANC PATIENT CANC SU
[5]   Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium [J].
Ayanian, JZ ;
Chrischilles, EA ;
Wallace, RB ;
Fletcher, RH ;
Fouad, MN ;
Kiefe, CI ;
Harrington, DP ;
Weeks, JC ;
Kahn, KL ;
Malin, JL ;
Lipscomb, J ;
Potosky, AL ;
Provenzale, DT ;
Sandler, RS ;
van Ryn, M ;
West, DW .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :2992-2996
[6]   Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program experience [J].
Buchanan, DR ;
White, JD ;
O'Mara, AM ;
Kelaghan, JW ;
Smith, WB ;
Minasian, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6682-6689
[7]   Racial differences in tumor stage and survival for colorectal cancer in an insured population [J].
Doubeni, Chyke A. ;
Field, Terry S. ;
Buist, Diana S. M. ;
Korner, Eli J. ;
Bigelow, Carol ;
Lamerato, Lois ;
Herrinton, Lisa ;
Quinn, Virginia R. ;
Hart, Gene ;
Hornbrook, Mark C. ;
Gurwitz, Jerry H. ;
Wagner, Edward H. .
CANCER, 2007, 109 (03) :612-620
[8]   Breast cancer treatment of older women in integrated health care settings [J].
Enger, Shelley M. ;
Thwin, Soe Soe ;
Buist, Diana S. M. ;
Field, Terry ;
Frost, Floyd ;
Geiger, Ann M. ;
Lash, Timothy L. ;
Prout, Marianne ;
Yood, Marianne Ulcickas ;
Wei, Feifei ;
Silliman, Rebecca A. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4377-4383
[9]   Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network [J].
Field, TS ;
Cernieux, J ;
Buist, D ;
Geiger, A ;
Lamerato, L ;
Hart, G ;
Bachman, D ;
Krajenta, R ;
Greene, S ;
Hornbrook, MC ;
Ansell, G ;
Herrinton, L ;
Reed, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (02) :148-152
[10]   Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy [J].
Geiger, AM ;
West, CN ;
Nekhlyudov, L ;
Herrinton, LJ ;
Liu, ILA ;
Altschuler, A ;
Rolnick, SJ ;
Harris, EL ;
Greene, SM ;
Elmore, JG ;
Emmons, KM ;
Fletcher, SV .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) :1350-1356